At-home programs may prescribe smaller doses (e.g., 100 mg ) injected subcutaneously (under the skin) on a more frequent schedule
Studies have shown that liposomal glutathione can achieve 8 to 12 times higher peak blood levels (Cmax) and a 600% to 2250% greater total absorption (AUC) compared to standard forms

Like cisplatin, it contains two chloride ligands, which are released within the cellular environment and interact with DNA to form intra- and interstrand cross-links.3 These DNA adducts trigger multiple cellular responses, including DNA damage recognition and repair, cell cycle arrest, and activation of apoptotic signaling pathways, ultimately inhibiting cell proliferation.4 Ovarian cancer remains one of the leading causes of mortality among gynecological malignancies, with epithelial ovarian carcinoma accounting for more than 90% of all cases.5 The current standard therapy involves primary cytoreductive surgery followed by platinum-based combination chemotherapy administered as soon as possible after surgery.6 However, a major limitation of these treatments is the dose-dependent toxicity associated with platinum compounds, which can result in significant off-target tissue injury.7 It is well established that Reactive Oxygen Species (ROS) generated during the metabolism of platinum-based agents contribute to this toxicity, particularly in the reproductive system

Glutathione deficiency in Parkinsons disease: a review of the literature
BPC-157 has not been evaluated in adequate, well-controlled human clinical trials
these data strongly suggest that subjects with idiopathic chronic cholestasis and personal or familial risk factors for inherited cholestasis, as well as DIC, ICP, or LPAC history, should be screened for a panel of primary cholestasis-related genes